Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Amy Vandenberg > Profile

Amy Vandenberg

Affiliations

Chief Clinical & Reg Officer at Obalon Therapeutics Inc (OBLN), 2020-01-28

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Obalon Therapeutics Inc	OBLN	$4.00	2,500		11,764	2019-08-06	Filing